{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T21:48:12Z","timestamp":1696628892031},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1016\/s0278-5846(01)00267-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:10:55Z","timestamp":1027591855000},"page":"287-291","source":"Crossref","is-referenced-by-count":3,"title":["Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin"],"prefix":"10.1016","volume":"26","author":[{"given":"Tsuyoshi","family":"Kondo","sequence":"first","affiliation":[]},{"given":"Masayuki","family":"Ishida","sequence":"additional","affiliation":[]},{"given":"Noboru","family":"Tokinaga","sequence":"additional","affiliation":[]},{"given":"Kazuo","family":"Mihara","sequence":"additional","affiliation":[]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[]},{"given":"Shingo","family":"Ono","sequence":"additional","affiliation":[]},{"given":"Sunao","family":"Kaneko","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0278-5846(01)00267-6_BIB1","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised (DSM-III-R)","year":"1987"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB2","first-page":"109","article-title":"Serum chlorpromazine and prolactin levels in paranoid schizophrenic patients and clinical response","author":"Bartko","year":"1988","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00431770","article-title":"Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice","volume":"87","author":"Bolvig Hansen","year":"1985","journal-title":"Psychopharmacology"},{"issue":"Suppl. 311","key":"10.1016\/S0278-5846(01)00267-6_BIB4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0447.1984.tb06860.x","article-title":"Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients","volume":"69","author":"Harnryd","year":"1984","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0033291700047942","article-title":"Adverse effects of anticholinergic medication in positive schizophrenic symptoms: theoretical and practical considerations","volume":"13","author":"Johnstone","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1192\/bjp.135.4.352","article-title":"Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study","volume":"135","author":"Kolakowska","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00007691-199404000-00002","article-title":"Adverse effects of zotepine and their relationship to serum concentrations of the drugs and prolactin","volume":"16","author":"Kondo","year":"1994","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004714-199902000-00009","article-title":"Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist","volume":"19","author":"Kondo","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004714-200008000-00003","article-title":"Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin","volume":"20","author":"Kondo","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 334","key":"10.1016\/S0278-5846(01)00267-6_BIB10","first-page":"11","article-title":"The UKU side effect rating scale","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00381354","article-title":"Haloperidol plasma levels and clinical response in paranoid schizophrenics","volume":"234","author":"Linkowski","year":"1984","journal-title":"Eur. Arch. Psychiatr. Neurol. Sci."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB12","first-page":"349","article-title":"A double-blind comparison of a new benzamide compound YM-09151 with haloperidol in the treatment of schizophrenia","volume":"17","author":"Mori","year":"1989","journal-title":"Clin. Eval."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-4347(98)00212-6","article-title":"High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection","volume":"714","author":"Nagasaki","year":"1998","journal-title":"J. Chromatogr., B"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1099-1077(199711\/12)12:6<591::AID-HUP926>3.0.CO;2-U","article-title":"Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients","volume":"12","author":"Otani","year":"1997","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1192\/bjp.136.6.591","article-title":"A pilot study of plasma thioridazine and metabolites in chronically treated patients","volume":"136","author":"Papadopoulos","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1192\/bjp.137.6.518","article-title":"Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia","volume":"137","author":"Rao","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB17","series-title":"Psychopharmacology, 3rd Generation of Progress","first-page":"803","article-title":"Prolactin and schizophrenia","author":"Rubin","year":"1987"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004850-199612000-00010","article-title":"Effects of nemonapride on positive and negative symptoms of schizophrenia","volume":"11","author":"Satoh","year":"1996","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1254\/jjp.69.399","article-title":"In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used","volume":"69","author":"Schotte","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/schbul\/16.2.185","article-title":"The role of estrogens in schizophrenia gender differences","volume":"16","author":"Seeman","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s002130000576","article-title":"Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia","volume":"153","author":"Spina","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(89)90516-5","article-title":"Comparison of [3H] YM-09151-2 with [3H] spiperone and [3H] raclopride for dopamine D-2 receptor binding to rat striatum","volume":"173","author":"Terai","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0278-5846(01)00267-6_BIB23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpsyc.1992.01820050018002","article-title":"Haloperidol blood levels and clinical effects","volume":"49","author":"Volavoka","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0278-5846(01)00267-6_BIB24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0447.1978.tb06929.x","article-title":"Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine","volume":"58","author":"Wode-Helgodt","year":"1978","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584601002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584601002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T06:56:07Z","timestamp":1556866567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584601002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0278584601002676"],"URL":"https:\/\/doi.org\/10.1016\/s0278-5846(01)00267-6","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}